Developer docs
API playgroundTry for free, no card

Search company profiles

Highlands Oncology

Full company profile

uuid000rxr5

Namestring
Highlands Oncology
Legal namestring
Highlands Oncology Group
Company typeenum
Private
Founded yearint
1996
Descriptiontext

Highlands Oncology Group is a private, physician-founded community oncology practice established in 1996 and headquartered in Springdale, Arkansas. The organization operates six clinical locations across Northwest Arkansas (Springdale; two in Rogers; two in Fayetteville; Mountain Home) and employs 501–1,000 staff including more than 30 physicians and advanced practice providers plus a 50-plus-person dedicated clinical trials research organization. It delivers comprehensive cancer care spanning medical, radiation, and surgical oncology, supported by integrated ancillary services including ACR-accredited diagnostic imaging (PET/CT/MRI), a CLIA-certified laboratory, an in-house specialty pharmacy at every clinic site, outpatient infusion centers, rehabilitation and massage therapy, registered dietitians, genetic counseling (the C.A.R.E. Clinic), supportive/palliative care, the Center for Chest Care, and a Wound, Ostomy & Continence Clinic.

The practice monetizes through three streams: standard medical services billing to Medicare (with accepted assignment) and a broad set of commercial PPO networks; pharmaceutical-sponsored clinical research with partners including Pfizer, BMS, and AstraZeneca, encompassing 140+ active oncology and hematology studies and operating as the only community-based Phase I oncology clinical trial center in Arkansas; and retail/specialty pharmacy dispensing. Go-to-market is physician-referral-led within the regional catchment, supplemented by direct patient intake (financial counseling and patient navigation), the Flatiron Health-powered CareSpace patient portal, and active participation in national forums such as the Community Oncology Alliance. Marketing channels include the company website, social media (Facebook, Instagram, LinkedIn, Google), earned-media press, and partnerships with community organizations such as Hope Cancer Resources and Collahealth.

Highlands has differentiated itself operationally by deploying third-party AI at scale across the patient journey: Canopy's AI phone operator "Kathy" handles approximately 20% of incoming calls; Reimagine Care's "Remi" AI care assistant supports remote patient monitoring; an ePRO and intelligent triage remote monitoring program was co-developed with Canopy; ambient scribes and automated fax processing reduce administrative load. In October 2025 the practice received the Association of Community Cancer Centers (ACCC) Innovator Award for that remote monitoring model. As of mid-2026, the organization is executing a CEO leadership transition, has opened a $4 million expanded clinical trials suite, and has broken ground on a seventh location (Rogers Cancer Center) while participating as a member of ONCare Alliance.

Short descriptiontext

Highlands Oncology Group is a physician-founded, community-based oncology practice operating six cancer centers across Northwest Arkansas, delivering medical, radiation, and surgical oncology plus diagnostic imaging, specialty pharmacy, lab, and clinical trial services to regional cancer patients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersSpringdale, United States
HQ citystring
Springdale
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oncology care services, cancer treatment center, radiation therapy, chemotherapy infusion, clinical trials research
Industry4 codes
PRIMARYHLAFABAI
Ambulatory Oncology Centers (Outpatient Chemo/Radiation)
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers
SECONDARYHLAFAHAC
Oncology & Cancer Specialty Hospitals
Healthcare & Life Sciences/Healthcare Providers & Systems/Specialty Hospitals & Inpatient Specialty Care
SECONDARYHLAKAFAB
Medical Oncology
SECONDARYHLAKAFAG
Surgical Oncology
NAICS code2 codes
  • Offices of Physicians62111
  • Other Outpatient Care Centers62149
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Oncology Care Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Services Billing
TypeSubscription Recurring
Description

Healthcare services revenue generated through billing insurance companies, Medicare, and patients directly. Accepts Medicare Assignment, all major health insurance plans, and PPO networks. Co-payments are due at time of service for PPO plans.

highlandsoncology.com
2Clinical Trials Research
TypeProfessional Services
Description

Revenue from pharmaceutical company partnerships for conducting clinical trials. Highlands serves as the only community-based Phase I oncology clinical trial center in Arkansas, conducting numerous studies in oncology and hematology with over 140 active clinical trials.

highlandsoncology.com
3On-site Pharmacy Services
TypeHardware Sales
Description

In-house pharmacy providing both IV medications during clinic visits and retail/specialty prescriptions. Pharmacists work directly with healthcare providers to ensure safe, timely, and effective treatment. Can fill prescriptions for patients' whole families.

highlandsoncology.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Pricing details1 tier
1Medicare patients pay deductible and 20% coinsurance
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Highlands accepts Medicare Assignment - accepts Medicare's approved rates for covered services. Patients responsible for annual deductible and 20% coinsurance unless supplemental coverage applies.

highlandsoncology.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1ONCare Alliance
Description

Strategic alliance that Highlands Oncology is part of, which seeks to empower independent practices, enhance community care, and foster innovation through a proprietary data engine and network of oncological practices.

highlandsoncology.com
Core offering1 text field

Highlands Oncology is a community-based cancer care center providing comprehensive oncology services including medical oncology, radiation oncology, surgical oncology, diagnostic imaging, in-house pharmacy, infusion therapy, and supportive care across six clinic locations in Northwest Arkansas. The practice also operates the only community-based Phase I oncology clinical trial center in Arkansas, conducting over 140 active clinical trials in oncology and hematology.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 70% reduction in emergency department visits with AI care assistant (Reimagine Care Remi)
+4 more records
Product overview1 text field

Highlands Oncology is a community oncology healthcare provider offering comprehensive cancer care services across Northwest Arkansas. The organization operates as a multi-specialty practice with six clinic locations providing Medical Oncology, Radiation Oncology, and Surgical Oncology as core services. The portfolio includes advanced treatment modalities such as IV Therapy, Immunotherapy, Targeted Therapy, Bispecific Therapy, and Theranostics/Radio-pharmaceuticals. Diagnostic capabilities encompass advanced imaging (PET, CT, MRI, Ultrasound, X-ray), CLIA-certified laboratory services, and a Specialty PET imaging program. The research division operates the only community-based Phase I clinical trial center in Arkansas. Support services include an on-site pharmacy, outpatient infusion centers, rehabilitation therapy, registered dietitians, genetic counseling (C.A.R.E. Clinic), supportive/palliative care, free lung cancer screening, and wound/ostomy care. Digital health offerings include the CareSpace patient portal and a remote monitoring program developed with Canopy. Highlands also provides emotional support services including Buddy Program, caregiver support groups, spiritual care, and cancer support groups.

Product and service2 records
1Medical Oncology
CategoryCore Service
Description

Diagnosis and treatment of cancers using chemotherapy, immunotherapy, targeted therapy, and hormone therapy. Medical oncologists act as primary care doctors and strategists for cancer treatment.

2Radiation Oncology
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-01-01
Description

Canopy provides AI-powered healthcare automation including Kathy, an AI phone operator that handles nearly 20% of incoming calls at Highlands Oncology, automating appointment scheduling and patient inquiries. Highlands also collaborated with Canopy to develop a tracking and symptom acuity system for remote patient monitoring.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-01-01
Description

Reimagine Care provides AI care assistant Remi, which reported 70% reduction in emergency department visits and 90% patient satisfaction across partner community practices including Highlands Oncology.

Strategic tierMajorTypeGTM or Marketing PartnerAnnounced on2025-01-01
Description

Highlands presented at the 2025 COA Community Oncology Conference on AI implementations, showcasing operational AI deployments for staffing and care delivery. COA provides platform for knowledge sharing and industry leadership.

4Other Community Oncology Practices
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Practices including Tennessee Oncology, Pontchartrain Cancer Center, and Florida Cancer Specialists & Research Institute presented together at COA conference on AI implementations, sharing learnings and best practices for ambient scribes and automated fax processing.

ajmc.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic alliance to empower independent practices, enhance community care, and foster innovation through a proprietary data engine and network of exceptional oncological practices. Redefines excellence in cancer care with agility, independence, and comprehensive support for clinical trials, advocacy, education, and training.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership providing personalized mental health support for patients' health journey. Collahealth works with physicians and is covered by insurance and Medicare, offering initial consultation, 1:1 specialist support, and weekly therapeutic sessions via telehealth or telephone.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Hope Cancer Resources provides emotional and financial support services. Licensed oncology social workers available Monday-Friday to ensure emotional and financial needs are being met for patients.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

PE-backed national partnership of independent community oncology practices providing practice management, technology, and clinical research support at scale. Comparable business model and target market to Highlands, with significantly greater capital resources and geographic reach.

TypeRegional player
Description

Northwest Arkansas-based health system with oncology services and hospital-based infusion, directly competing with Highlands for patients in the Fayetteville and surrounding markets. Closest regional hospital competitor in Highlands' core footprint.

TypeBroad incumbent
Description

The largest network of community-based oncology practices in the US, owned by McKesson, offering centralized services, clinical trials, and technology to affiliated practices. Represents both a competitor and a potential affiliation path for independent community oncology practices like Highlands.

TypeDirect peer
Description

Community oncology practice in Louisiana offering chemotherapy, radiation, and clinical trial services in a regional setting. Co-presented with Highlands at the 2025 COA conference, indicating similar operational maturity and adoption of ambient scribes and automated fax AI workflows.

TypeRegional player
Description

Large hospital system operating across Arkansas including Northwest Arkansas with employed oncology programs and infusion services. Represents a regional competitor for patient referrals and physician employment in Highlands' core geography.

TypeDirect peer
Description

Multi-site community oncology practice serving Tennessee with comprehensive medical, radiation, and hematology services and an active clinical trials program. Co-presented with Highlands at the 2025 Community Oncology Alliance conference on AI implementations, making it one of the most directly comparable community oncology peers.

TypeEmerging player
Description

Fast-growing network of community oncology practices offering medical oncology, hematology, and pharmacy services with centralized back-office and clinical research support. Comparable target patient base and multi-site community oncology model, though typically smaller and earlier stage than Highlands.

TypeDirect peer
Description

Large physician-owned community oncology practice with hundreds of providers across Florida offering medical oncology, hematology, radiation oncology, imaging, and clinical trials. Co-presented with Highlands at the 2025 COA conference on AI deployments, sharing similar GTM and operational scale.

9Sarah Cannon Research Institute
TypeBroad incumbent
Description

HCA-affiliated clinical research network focused on oncology Phase I-III trials across community and academic sites. Direct overlap with Highlands' Phase I trial program and pharmaceutical partnerships, though at much larger network scale through HCA.

TypeBroad incumbent
Description

National cancer research and treatment system operating specialty oncology hospitals, outpatient centers, and clinical trials programs after acquiring Cancer Treatment Centers of America. Comparable comprehensive oncology menu but operates at significantly larger scale and includes inpatient specialty hospital settings Highlands does not.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Highlands Oncology

Oncology Care Serviceshighlandsoncology.com

Highlands Oncology Group is a physician-founded, community-based oncology practice operating six cancer centers across Northwest Arkansas, delivering medical, radiation, and surgical oncology plus diagnostic imaging, specialty pharmacy, lab, and clinical trial services to regional cancer patients.

What Highlands Oncology does

Highlands Oncology Group is a private, physician-founded community oncology practice established in 1996 and headquartered in Springdale, Arkansas. The organization operates six clinical locations across Northwest Arkansas (Springdale; two in Rogers; two in Fayetteville; Mountain Home) and employs 501–1,000 staff including more than 30 physicians and advanced practice providers plus a 50-plus-person dedicated clinical trials research organization. It delivers comprehensive cancer care spanning medical, radiation, and surgical oncology, supported by integrated ancillary services including ACR-accredited diagnostic imaging (PET/CT/MRI), a CLIA-certified laboratory, an in-house specialty pharmacy at every clinic site, outpatient infusion centers, rehabilitation and massage therapy, registered dietitians, genetic counseling (the C.A.R.E. Clinic), supportive/palliative care, the Center for Chest Care, and a Wound, Ostomy & Continence Clinic.

The practice monetizes through three streams: standard medical services billing to Medicare (with accepted assignment) and a broad set of commercial PPO networks; pharmaceutical-sponsored clinical research with partners including Pfizer, BMS, and AstraZeneca, encompassing 140+ active oncology and hematology studies and operating as the only community-based Phase I oncology clinical trial center in Arkansas; and retail/specialty pharmacy dispensing. Go-to-market is physician-referral-led within the regional catchment, supplemented by direct patient intake (financial counseling and patient navigation), the Flatiron Health-powered CareSpace patient portal, and active participation in national forums such as the Community Oncology Alliance. Marketing channels include the company website, social media (Facebook, Instagram, LinkedIn, Google), earned-media press, and partnerships with community organizations such as Hope Cancer Resources and Collahealth.

Highlands has differentiated itself operationally by deploying third-party AI at scale across the patient journey: Canopy's AI phone operator "Kathy" handles approximately 20% of incoming calls; Reimagine Care's "Remi" AI care assistant supports remote patient monitoring; an ePRO and intelligent triage remote monitoring program was co-developed with Canopy; ambient scribes and automated fax processing reduce administrative load. In October 2025 the practice received the Association of Community Cancer Centers (ACCC) Innovator Award for that remote monitoring model. As of mid-2026, the organization is executing a CEO leadership transition, has opened a $4 million expanded clinical trials suite, and has broken ground on a seventh location (Rogers Cancer Center) while participating as a member of ONCare Alliance.

Highlands Oncology firmographics

Firmographics
Name
Highlands Oncology
Legal name
Highlands Oncology Group
Website
https://highlandsoncology.com
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Highlands Oncology Group is a physician-founded, community-based oncology practice operating six cancer centers across Northwest Arkansas, delivering medical, radiation, and surgical oncology plus diagnostic imaging, specialty pharmacy, lab, and clinical trial services to regional cancer patients.
Ownership category
akta.pro rank

Highlands Oncology industry classification

Industry
Product category
Oncology Care Services
NAICS
Offices of Physicians (62111), Other Outpatient Care Centers (62149)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro industry
PRIMARYHLAFABAI
Ambulatory Oncology Centers (Outpatient Chemo/Radiation)
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers
SECONDARYHLAFAHAC
Oncology & Cancer Specialty Hospitals
Healthcare & Life Sciences/Healthcare Providers & Systems/Specialty Hospitals & Inpatient Specialty Care
SECONDARYHLAKAFAB
Medical Oncology
SECONDARYHLAKAFAG
Surgical Oncology

Keywords

  • Oncology care services
  • Cancer treatment center
  • Radiation therapy
  • Chemotherapy infusion
  • Clinical trials research

Where Highlands Oncology is headquartered

Location

Headquarters

HQ city
Springdale
HQ country
United States
HQ region
North America

Offices6 records

Markets served

Highlands Oncology business model

Business model
GTM type
B2C
Offering type
Services

Revenue model

  1. Medical Services Billing: Healthcare services revenue generated through billing insurance companies, Medicare, and patients directly. Accepts Medicare Assignment, all major health insurance plans, and PPO networks. Co-payments are due at time of service for PPO plans.
  2. Clinical Trials Research: Revenue from pharmaceutical company partnerships for conducting clinical trials. Highlands serves as the only community-based Phase I oncology clinical trial center in Arkansas, conducting numerous studies in oncology and hematology with over 140 active clinical trials.
  3. On-site Pharmacy Services: In-house pharmacy providing both IV medications during clinic visits and retail/specialty prescriptions. Pharmacists work directly with healthcare providers to ensure safe, timely, and effective treatment. Can fill prescriptions for patients' whole families.

Pricing tiers

ModelBillingPrice
SubscriptionPay-as-you-goMedicare patients pay deductible and 20% coinsurance

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Highlands Oncology product offering

Product offering

Core offering

Highlands Oncology is a community-based cancer care center providing comprehensive oncology services including medical oncology, radiation oncology, surgical oncology, diagnostic imaging, in-house pharmacy, infusion therapy, and supportive care across six clinic locations in Northwest Arkansas. The practice also operates the only community-based Phase I oncology clinical trial center in Arkansas, conducting over 140 active clinical trials in oncology and hematology.

Product overview

Highlands Oncology is a community oncology healthcare provider offering comprehensive cancer care services across Northwest Arkansas. The organization operates as a multi-specialty practice with six clinic locations providing Medical Oncology, Radiation Oncology, and Surgical Oncology as core services. The portfolio includes advanced treatment modalities such as IV Therapy, Immunotherapy, Targeted Therapy, Bispecific Therapy, and Theranostics/Radio-pharmaceuticals. Diagnostic capabilities encompass advanced imaging (PET, CT, MRI, Ultrasound, X-ray), CLIA-certified laboratory services, and a Specialty PET imaging program. The research division operates the only community-based Phase I clinical trial center in Arkansas. Support services include an on-site pharmacy, outpatient infusion centers, rehabilitation therapy, registered dietitians, genetic counseling (C.A.R.E. Clinic), supportive/palliative care, free lung cancer screening, and wound/ostomy care. Digital health offerings include the CareSpace patient portal and a remote monitoring program developed with Canopy. Highlands also provides emotional support services including Buddy Program, caregiver support groups, spiritual care, and cancer support groups.

Differentiator

Problem solved

Functional benefit

Brands

  • ONCare Alliance: Strategic alliance that Highlands Oncology is part of, which seeks to empower independent practices, enhance community care, and foster innovation through a proprietary data engine and network of oncological practices.

Products and services

  • Medical Oncology Diagnosis and treatment of cancers using chemotherapy, immunotherapy, targeted therapy, and hormone therapy. Medical oncologists act as primary care doctors and strategists for cancer treatment.
  • Radiation Oncology

Quantifiable outcome

  • 70% reduction in emergency department visits with AI care assistant (Reimagine Care Remi)
  • +4 more outcomes

Companies that use Highlands Oncology

Customer profile

Named customers1 record

Segments4 records

Highlands Oncology technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability5 records

Feature4 records

Highlands Oncology partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core, major and minor.

  • CanopycoreTechnology or Integration · 1 January 2025Canopy provides AI-powered healthcare automation including Kathy, an AI phone operator that handles nearly 20% of incoming calls at Highlands Oncology, automating appointment scheduling and patient inquiries. Highlands also collaborated with Canopy to develop a tracking and symptom acuity system for remote patient monitoring.
  • Reimagine CarecoreTechnology or Integration · 1 January 2025Reimagine Care provides AI care assistant Remi, which reported 70% reduction in emergency department visits and 90% patient satisfaction across partner community practices including Highlands Oncology.
  • Community Oncology Alliance (COA)majorGTM or Marketing Partner · 1 January 2025Highlands presented at the 2025 COA Community Oncology Conference on AI implementations, showcasing operational AI deployments for staffing and care delivery. COA provides platform for knowledge sharing and industry leadership.
  • Other Community Oncology PracticesminorStrategic or Co-development Partner · 1 January 2025Practices including Tennessee Oncology, Pontchartrain Cancer Center, and Florida Cancer Specialists & Research Institute presented together at COA conference on AI implementations, sharing learnings and best practices for ambient scribes and automated fax processing.
  • ONCare AlliancecoreStrategic or Co-development PartnerStrategic alliance to empower independent practices, enhance community care, and foster innovation through a proprietary data engine and network of exceptional oncological practices. Redefines excellence in cancer care with agility, independence, and comprehensive support for clinical trials, advocacy, education, and training.
  • CollahealthminorStrategic or Co-development PartnerPartnership providing personalized mental health support for patients' health journey. Collahealth works with physicians and is covered by insurance and Medicare, offering initial consultation, 1:1 specialist support, and weekly therapeutic sessions via telehealth or telephone.
  • Hope Cancer ResourcesminorStrategic or Co-development PartnerHope Cancer Resources provides emotional and financial support services. Licensed oncology social workers available Monday-Friday to ensure emotional and financial needs are being met for patients.

Scale indicators9 records

Recent moves9 records

Expansion highlights6 records

Highlands Oncology competitors and assessment

Company assessment

Broad incumbents

  • OneOncology: PE-backed national partnership of independent community oncology practices providing practice management, technology, and clinical research support at scale. Comparable business model and target market to Highlands, with significantly greater capital resources and geographic reach.
  • US Oncology Network (McKesson): The largest network of community-based oncology practices in the US, owned by McKesson, offering centralized services, clinical trials, and technology to affiliated practices. Represents both a competitor and a potential affiliation path for independent community oncology practices like Highlands.
  • Sarah Cannon Research Institute: HCA-affiliated clinical research network focused on oncology Phase I-III trials across community and academic sites. Direct overlap with Highlands' Phase I trial program and pharmaceutical partnerships, though at much larger network scale through HCA.
  • City of Hope: National cancer research and treatment system operating specialty oncology hospitals, outpatient centers, and clinical trials programs after acquiring Cancer Treatment Centers of America. Comparable comprehensive oncology menu but operates at significantly larger scale and includes inpatient specialty hospital settings Highlands does not.

Regional players

  • Washington Regional Medical System: Northwest Arkansas-based health system with oncology services and hospital-based infusion, directly competing with Highlands for patients in the Fayetteville and surrounding markets. Closest regional hospital competitor in Highlands' core footprint.
  • Baptist Health (Arkansas): Large hospital system operating across Arkansas including Northwest Arkansas with employed oncology programs and infusion services. Represents a regional competitor for patient referrals and physician employment in Highlands' core geography.

Direct peers

  • Pontchartrain Cancer Center: Community oncology practice in Louisiana offering chemotherapy, radiation, and clinical trial services in a regional setting. Co-presented with Highlands at the 2025 COA conference, indicating similar operational maturity and adoption of ambient scribes and automated fax AI workflows.
  • Tennessee Oncology: Multi-site community oncology practice serving Tennessee with comprehensive medical, radiation, and hematology services and an active clinical trials program. Co-presented with Highlands at the 2025 Community Oncology Alliance conference on AI implementations, making it one of the most directly comparable community oncology peers.
  • Florida Cancer Specialists & Research Institute: Large physician-owned community oncology practice with hundreds of providers across Florida offering medical oncology, hematology, radiation oncology, imaging, and clinical trials. Co-presented with Highlands at the 2025 COA conference on AI deployments, sharing similar GTM and operational scale.

Emerging players

  • American Oncology Network: Fast-growing network of community oncology practices offering medical oncology, hematology, and pharmacy services with centralized back-office and clinical research support. Comparable target patient base and multi-site community oncology model, though typically smaller and earlier stage than Highlands.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Highlands Oncology social profiles

Digital presence

Highlands Oncology compliance and trust

Trust signal

Compliance2 records

Highlands Oncology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Highlands Oncology leadership team

Management profile

Number of profiles

Highlands Oncology funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Highlands Oncology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Highlands Oncology

What does Highlands Oncology do?

Highlands Oncology is a community-based cancer care center providing comprehensive oncology services including medical oncology, radiation oncology, surgical oncology, diagnostic imaging, in-house pharmacy, infusion therapy, and supportive care across six clinic locations in Northwest Arkansas. The practice also operates the only community-based Phase I oncology clinical trial center in Arkansas, conducting over 140 active clinical trials in oncology and hematology.

Is Highlands Oncology a public or private company?

Highlands Oncology is a private company. It is currently operating.

When was Highlands Oncology founded?

Highlands Oncology was founded in 1996. It employs 501 to 1,000 people.

Where is Highlands Oncology based?

Highlands Oncology is headquartered in Springdale, United States, in the North America region.

How does Highlands Oncology make money?

Three revenue lines are on record. Medical Services Billing is the primary driver. The others are clinical Trials Research and on-site Pharmacy Services.

Who are Highlands Oncology's main competitors?

Broad incumbents on record are OneOncology, US Oncology Network (McKesson), Sarah Cannon Research Institute and City of Hope. Regional players are Washington Regional Medical System and Baptist Health (Arkansas). Direct peers are Pontchartrain Cancer Center, Tennessee Oncology and Florida Cancer Specialists & Research Institute. American Oncology Network is listed as an emerging player.

Does Highlands Oncology have an API?

No public API is recorded for Highlands Oncology.

What industry is Highlands Oncology in?

Highlands Oncology's product category is Oncology Care Services. Its primary akta.pro industry code is HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation), with a secondary code of HLAFAHAC, Oncology & Cancer Specialty Hospitals. Its NAICS code is 62111 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ArkansasbusinessAs Threats Rise, Arkansas Healthcare Providers Beef Up SecurityArkansas healthcare providers are hiring private security firms to protect staff as workplace violence rises. Highlands Oncology hired SafeHaven Security Group, which provides armed security officers at its locations. The annual cost of these services was not disclosed.Talk Business & PoliticsConstruction starts on 7th Highlands Oncology CenterHighlands Oncology broke ground on a five-story, 125,000-square-foot cancer center in Rogers, Arkansas, on Interstate 49. The Rogers Cancer Center is slated to open in the third quarter of 2028 and will be the company's seventh location. The company has more than doubled in size over seven years.Talk Business & PoliticsJeff Hunnicutt to step down as CEO of Highlands OncologyJeff Hunnicutt is stepping down as CEO of Highlands Oncology, effective Friday, after nearly eight years. The board will begin a CEO search, with Dr. Thad Beck as interim CEO. Highlands Oncology has doubled in size under his leadership and recently broke ground on a new cancer center.Talk Business & PoliticsHighlands Oncology opens $4 million clinical trials suiteHighlands Oncology invested about $4 million in an expanded clinical trials suite at its Springdale center. The 12,100-square-foot facility supports 150 active trials with 250 enrolled patients and over 60 research staff. The company aims to bring innovative cancer therapies to its community.AJMCAI in Oncology Practice: Innovation in the Delivery of Care ItselfThe Community Oncology Alliance (COA) held its 2025 Community Oncology Conference with AI as the central theme, showcasing how oncology practices are deploying AI tools to address staffing shortages, physician burnout, and extend high-quality care beyond office walls. Multiple practices including Highlands Oncology, Tennessee Oncology, Pontchartrain Cancer Center, and Florida Cancer Specialists & Research Institute presented operational implementations such as ambient scribes for clinical documentation and automated fax processing. Two AI platforms were highlighted: Canopy's AI phone operator Kathy, which handles nearly 20% of incoming calls at Highlands Oncology, and Reimagine Care's AI care assistant Remi, which reported a 70% reduction in emergency department visits and 90% patient satisfaction across partner community practices.Talk Business & PoliticsHighlands Oncology receives innovator awardSpringdale-based Highlands Oncology, the region’s largest cancer-care provider, received a 2025 Association of Cancer Care Centers Innovator Award for its remote monitoring model that provides symptom management support to patients between clinic visits. The model uses electronic patient-reported outcomes and intelligent triage technology to reduce emergency department visits and hospital admissions while increasing treatment adherence and patient engagement. Highlands collaborated with software developer Canopy to develop the tracking and symptom acuity system that prompted patients to report to providers when additional care was required.PR NewswireDATA BREACH ALERT: Edelson Lechtzin LLP is Investigating Claims on Behalf of Highlands Oncology Group PA Customers Whose Data May Have Been CompromisedHighlands Oncology Group PA, a cancer treatment center in Fayetteville, Arkansas, discovered a cyberattack on or around June 2, 2025, in which an unauthorized third party accessed and encrypted files between January 21, 2025, and June 2, 2025. The breach may have compromised personal information including names, Social Security numbers, medical records, and financial account details of up to 113,575 individuals. Edelson Lechtzin LLP, a class action law firm, is now investigating potential legal claims on behalf of those affected.PR NewswireAt ASCO 2017 Clinicians Present New Evidence about Watson Cognitive Technology and Cancer CareIBM Watson Health presented clinical evidence at ASCO 2017 demonstrating that its Watson for Oncology technology matched tumor board treatment recommendations in up to 96% of lung cancer cases and reduced clinical trial screening time by 78% in a pilot with Highlands Oncology Group and Novartis. The company announced the expansion of Watson for Oncology to support prostate cancer treatment, with the technology now available across 55 hospitals and health organizations in 15 countries and covering 80% of global cancer incidence by year-end. Memorial Sloan Kettering Cancer Center continues as the primary training partner for the system.